Top Markets
#1 DogBull DogBull +108.55%
#2 MarsCoin MarsCoin +76.65%
#3 Siacoin Siacoin +56.43%
#4 ADO Protocol ADO Protocol +52.50%
#5 Ontology Gas Ontology Gas +32.10%
#6 The Bitcoin Bull The Bitcoin Bull +30.29%
#7 Apertum Apertum +16.15%
#8 Pons Pons +13.49%
#9 Useless Coin Useless Coin +12.60%
#10 Stratis Stratis +12.32%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Rank in Stocks #15117
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Share Price
$4.74
Last synced: 2026-08-31
Market Cap
$372.19M
Change (1 day)
-2.47%
Change (1 year)
-1.04%
Country
US
Trade Lexeo Therapeutics, Inc. Common Stock (LXEO)

Category

Healthcare
Operating Margin for Lexeo Therapeutics, Inc. Common Stock (LXEO)
Operating Margin as of 2026 TTM: 0.00%
According to Lexeo Therapeutics, Inc. Common Stock latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Lexeo Therapeutics, Inc. Common Stock from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.57% -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.